Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions
US7781451B2 · kind B2 · utility
1Cited by
17References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2005 |
| Grant date | Aug 24, 2010 |
| Priority date | — |
| Expiry date | Jan 28, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of the formulawhich are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.